Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model
Dow Jones Industrial Average
) is trading down 3.0 points at 14,697 as of Friday, Apr 26, 2013, 9:35 a.m. ET. During this time, 24.7 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 601.7 million. The NYSE advances/declines ratio sits at 1,082 issues advancing vs. 1,332 declining with 194 unchanged.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The Dow component leading the way higher looks to be
), which is sporting a $1.04 gain (+0.9%) bringing the stock to $119.54. Volume for Chevron currently sits at 227,760 shares traded vs. an average daily trading volume of 5.7 million shares.
Chevron has a market cap of $229.29 billion and is part of the basic materials sector and energy industry. Shares are up 9.6% year to date as of Thursday's close. The stock's dividend yield sits at 3.4%.
Chevron Corporation, through its subsidiaries, engages in petroleum, chemicals, mining, power generation, and energy operations worldwide. The company operates in two segments, Upstream and Downstream. The company has a P/E ratio of 8.9, below the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Chevron as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.
- You can view the full Chevron Ratings Report.
Holding back the Dow today is
), which is lagging the broader Dow index with an 80-cent decline (-2.7%) bringing the stock to $29.46. This single loss is lowering the Dow Jones Industrial Average by 6.05 points or roughly accounting for 201.7% of the Dow's overall loss. Volume for Pfizer currently sits at 5.8 million shares traded vs. an average daily trading volume of 31.6 million shares.
Pfizer has a market cap of $219.88 billion and is part of the health care sector and drugs industry. Shares are up 20.7% year to date as of Thursday's close. The stock's dividend yield sits at 3.1%.
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. The company has a P/E ratio of 24.3, above the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Pfizer as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow.
- You can view the full Pfizer Ratings Report.
Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE